Description

BioHale® portfolio, comprised by BioHale® Sucrose and BioHale® Trehalose Dihydrate, can be used in various administration forms, such as for parenteral, inhalation, oral or ophthalmic route. BioHale® enables the stabilization of biologics in biopharmaceutical formulations and among many other biologic treatments, BioHale® is already used in several of the current vaccines against COVID-19. BioHale® portfolio ensures highest purity of excipients low in endotoxin.

Features

  • Vaccine Adjuvant
  • Stabiliser

Unfortunately, not all our products and suppliers are listed on this website for immediate browsing. If you're unable to find a specific product or supplier, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬 𝐝𝐢𝐫𝐞𝐜𝐭𝐥𝐲 𝐨𝐫 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐚𝐭 𝐌𝐲𝐈𝐌𝐂𝐃 - 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐏𝐨𝐫𝐭𝐚𝐥. By doing so, you will gain full access to our comprehensive product list and documentation, ensuring you have all the information you need. Thank you for choosing us, and we look forward to assisting you!

How can we help you with BIOHALE?

I am looking for...